News - 06 Feb `23Vitiligo Clinical Trials update

New

Clinical trials are experiments that test how well new drugs, treatments or devices work in people. Trials progress through Phases I-IV to test a drug candidate, find the appropriate dosage, and look for side effects. The goal is to determine whether a medicine is both safe and effective. Drug candidates that have entered into clinical trials or pending approval by the U.S. Food and Drug Administration (FDA) are often said to be "in the pipeline." 

Our Trials Hub provides a comprehensive list of more than 20 active clinical trials located in Bangladesh, Canada, Egypt, France, Israel, and the United States.

👉 UPDATE February 6, 2023: New study posted "A Phase 1, Single and Multiple Ascending Dose (SAD/MAD) Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of VYN201 in Healthy Volunteers and in Subjects with Non-Segmental Vitiligo (NSV)" from Vyne Therapeutics.

Our CEO Yan Valle analyzes and monitors the entire drug development landscape along with the trends shaping and driving the vitiligo market, and reports findings in Vitiligo Drug Pipeline Analysis and Market Insights

 

Vitiligo clinical trials selector

 



      FAQOther Questions

      • Will it spread?

        Vitiligo's progression and response to treatment can vary significantly among individuals, making it a particularly unpredictable skin condition. Based on the VALIANT study, her...

      • How can I explain vitiligo to my children?

        Vitiligo can be confusing for children because it doesn’t resemble an "illness" in the typical sense. Choosing the right way to explain it depends on your child’s age and maturi...

      • Pyrostegia venusta as a folk medicine for vitiligo?

        Pyrostegia venusta, also known as “flame vine” or “cipó-de-são-joão,” is a neotropical evergreen vine native to Brazil. It thrives in fields, coastal areas, forest edges, and ro...